Eli Lilly and Company (LLY)
Market Closed
27 Feb, 20:00
$
1,052. 20
+30.18
+2.95%
Pre Market
$
-10.21 -0.97% 1,041. 99
970.55B Market Cap
104.2 P/E Ratio
6% Div Yield
2,455,171 Volume
6.64 Eps
$ 1,022.02
Previous Close Day Range
1,017.36 1,052.83
Year Range
623.78 1,133.95
Want to track LLY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
LLY earnings report is expected in 58 days (29 Apr 2026)
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Eli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
Zacks | 1 year ago
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks | 1 year ago
3 Drug Stocks to Watch on Raised 2024 Earnings & Sales Guidance
Here we discuss three drugmakers, Eli Lilly and Company (LLY), Novo Nordisk (NVO) and Merck (MRK), that have raised their earnings as well as sales guidance for 2024.
Zacks | 1 year ago
